Navigation Links
First results from major European patient survey show devastating impact of living with breakthrough cancer pain
Date:9/11/2009

Lisbon, Portugal 11 September, 2009 The first results of the first European survey of cancer patients experience of breakthrough pain were presented today at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC).

Previous surveys have looked at the overall management of pain in cancer patients but this is the first international study to look in detail at Breakthrough Cancer Pain (BTCP) from a patient perspective. These results for the first 200 patients from the UK, Sweden and Denmark offer valuable insight into cancer patients experiences with breakthrough pain management and the impact of the condition on their daily lives.

  • The median number of BTCP episodes per patient per day was 3
  • Each episode had a median duration of 60 minutes
  • 96% of the pain episodes were described as moderate to severe
  • For 90% of patients their BTCP interfered with their daily living including their ability to sleep, walk and get on with other people

The study documents that breakthrough pain has a significant impact on cancer patients daily lives, explained Dr. Andrew Davies, Department of Palliative Medicine, Royal Marsden Hospital, UK and the principal investigator of this survey. Breakthrough pain is very different to background pain. Background pain is a continuous, chronic pain requiring around-the-clock medication. Breakthrough pain is a fast onset, short duration, intense pain that breaks through the chronic pain even when this is being controlled with medication. It is incapacitating and very distressing to the patient.

For this kind of pain episode the ideal treatment would be fast acting with a short duration of action to most closely match the nature of BTCP episodes. Moreover, it must be easy to use to improve patient compliance. However, the results of the survey show that:

  • At least 95% of patients were using orally administered dr
    '/>"/>

Contact: Mette Thorn Srensen
mts@cohnwolfe.dk
454-138-4300
Cohn & Wolfe, Copenhagen
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Tampa Personal Injury Lawyer Timothy Anderson, Jr. Joins Father's Law Firm, Takes Five Cases To Jury Trial In First Eighteen Months
2. NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery
3. LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL(TM) Technology
4. The CRIMSON Initiative - the First Physician Performance Data Management Platform Developed By Physicians For Physicians - is Now Working With Over 200 Hospitals and Over 25,000 Doctors
5. First Cape Cod Macular Degeneration Symposium To Be Held on September 17
6. Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System
7. First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain
8. Allscripts to Announce Fiscal First Quarter Results on September 29, 2009; Company Appoints Vice President of Investor Relations
9. Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate
10. First-Ever NJ Psoriasis Walk Coming to Paramus on Sept. 12
11. RBC Life Sciences Unveils the ClearPay System - the Industrys First Balancing Compensation Plan That Pays Quickly and Abundantly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... release is available in French . ... revolutionize surgical practice and regenerative medicine. A team led ... Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur from the ... 13), has just demonstrated that the principle of adhesion ... vivo to repair soft-tissue organs and tissues. This easy-to-use ...
(Date:4/17/2014)... Scientists have identified new pain relief targets that ... pain. BBSRC-funded researchers at King,s College London made ... nerves in the periphery of the body. , ... and identifying mechanisms underlying pain generation and our ... related side effects." , One potential side effect ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... Boston University School of Medicine (BUSM) have discovered ... in an experimental model. The findings, reported in ... Abuse , may lead to more effective treatments ... one of the leading causes of illness and ... economic impact by limiting the productivity of workers ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced ... Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY ) as,its ... announced transaction,between Takeda Pharmaceutical Company Limited and Alnylam. ... of future milestone and royalty,payments. This transaction further ...
... of almonds closer to that of roses or bananas? Weizmann ... for the first time that smells can be mapped and ... appeared recently in Nature Methods, may help scientists to unravel ... as potentially enabling odors to be digitized and transferred via ...
... Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) (,Lotus, or the ... China ("PRC"), today,announced that it will conduct a ... May 27, 2008 to discuss the first quarter ... and Chief Executive Officer of Lotus,Pharmaceuticals, will be ...
... ON, May 27 /PRNewswire-FirstCall/ - AlphaRx (OTC ... proprietary drug,delivery technology to develop novel formulations ... and USAMRIID (U.S. Army Medical Research Institute ... Research and,Development Agreement for Material Transfer (MTA). ...
... UCLA have identified a type of leukemia stem cell and ... blood stem cells to become cancerous. , The discovery may ... attacking the disease at its very root and killing the ... The study appears in the May 22, 2008 issue of ...
... Dozens of Videos from Doctors and Students at Seattle Children,s Hospital, Swedish ... ... Available,Videos Offer Insight and Advice on Topics Ranging from Pediatrics to Cancer ... Screening to Novel Surgical Techniques, NEW YORK, May 27 ...
Cached Medicine News:Health News:Isis to Receive $4.6 Million From Alnylam 2Health News:Isis to Receive $4.6 Million From Alnylam 3Health News:Weizmann Institute scientists produce the first smell map 2Health News:Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 3Health News:AlphaRx Signs Cooperative Research and Development Agreement with US Army 2Health News:UCLA researchers identify leukemia stem cells 2Health News:The Doctor's Channel Launches New Videos from Three Top Hospitals 2Health News:The Doctor's Channel Launches New Videos from Three Top Hospitals 3
(Date:1/15/2014)... , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds ... its store . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ... upgrade and policy support, China,s ... years, with total market size rising from 3.28 billion ...
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... , January 15, 2014 BreedIT Corp ... exclusive worldwide distributor of highly sophisticated agro-breeding solutions for ... 7, 2014, the Company,s board of directors appointed chemistry ... as its new member of the board. ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... Confirms Effectiveness of Autologous Therapy, DUSSELDORF, ... a two-year,representative study of knee osteoarthritis, published ... confirm,the safety and effectiveness of Orthokine therapy, ... own blood are,injected into the arthritic joint., ...
... Phase III Study to Explore the Effects of ... Calcitonin on Vertebral Fractures in Postmenopausal Women, ... (Nasdaq: EMIS ) announced today that Novartis ... III study exploring the,safety and efficacy of Salmon ...
Cached Medicine Technology:Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years 2Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment 2
... The aliquot! The aliquot from Genetix is ... with 96, 384, and 1536 well microplates. ... backfilling facility and optional microplate stacker, the ... low volume dispensing needs. The aliQuot's compact ...
... is a compact and self-contained multichannel ... a unique flow-through device, which allows ... wash system. Optional refill system ... Will be upgradable to with ...
... Aquarius 96 is a compact and self-contained ... fixed tip manifold can be used in ... washed in the optional active wash system. ... dust and adds safety. ...
... ideal system for fast, accurate filling of 96 ... valve controlled dispensing mechanism, ensures that no liquid ... components that come into contact with the liquid ... The unique compact design saves valuable bench space ...
Medicine Products: